Clinical Trial Update: A Phase II Efficacy Study in Fistulizing Crohn's Disease Patients [Phase 2]

View source ↗

Summary

An update on a Phase II efficacy trial for fistulizing Crohn's disease sponsored by Novartis. The trial status is completed, and no results are provided in the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Crohn's Disease | Phase 2 | Status: COMPLETED